fda compounding semaglutide crackdown 2025 news Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots Counterfeit Ozempic Crackdown: Drugmakers Threaten

Conagra, for example, has changed the packaging of some Healthy Choice meals to include a GLP-1 friendly label

The retatrutide and hair loss article explores whether the compound itself contributes beyond simple caloric restriction, and the broader GLP-1 hair loss guide covers prevention strategies

For example, Wegovy (semaglutide) was approved for chronic weight management by the FDA in 2021

It is currently under clinical investigation and has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

Wegovy (semaglutide injection, Novo Nordisk), Zepbound (tirzepatide injection, Eli Lilly), Saxenda (liraglutide injection, Novo Nordisk), and oral Wegovy (semaglutide tablets, approved December 2025)